Australia approves Stryker's OP-1 implant
This article was originally published in Clinica
Australia has become the first country to approve for sale Stryker's OP-1 implant for inducing bone formation. The Australian Therapeutic Goods Administration has given the Cambridge, Massachusetts firm the green light to market the implant as a treatment for nonunion of long bone fractures secondary to trauma for the purposes of initiating repair by new bone formation.
You may also be interested in...
After urging the US Congress to act on updating Medicare Part D, the Association for Accessible Medicines has welcomed the decision to update Part D by the Centers for Medicare & Medicaid Services of the US Department of Health and Human Services.
Dr Reddy’s signals a sharp step up in ambitions at home, propelled by building leadership in 10 therapy segments and an “India-first” approach for specialty products. Uptick in the China business and the potential launch of a Russia-partnered COVID-19 vaccine were other aspects of the business discussed at JPM.
“You can’t just live off the brand equity anymore,” warned J&J's Consumer Health's Minoj Raghunandanan during the ‘Advancing Trust in the Self-Care Industry’ webinar co-hosted by the Global Self-Care Federation and HBW Insight. “You’ve got to continue to build that trust between consumers and products day-in day-out.”